Last update 26 Nov 2024

AWT-020

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
AWT 020, AWT020
Target
IL-2R x PD-1
Mechanism
IL-2R agonists(Interleukin-2 receptor agonists), PD-1 inhibitors(Programmed cell death protein 1 inhibitors)
Therapeutic Areas
NeoplasmsRespiratory DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication
MelanomaNon-Small Cell Lung CancerRenal Cell Carcinoma+ [1]
Inactive Indication-
Originator Organization
Anwita Biosciences, Inc.Anwita Biosciences, Inc.
Active Organization
Anwita Biosciences, Inc.Anwita Biosciences, Inc.Shanghai Junshi Biosciences Co., Ltd.Shanghai Junshi Biosciences Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AWT-020
NCT06092580 / RecruitingPhase 1
A Phase 1/2, First-in-human, Open-label Study of Single-agent AWT020 in Patients With Progressive Locally Advanced or Metastatic Cancer
100 Clinical Results associated with AWT-020
Login to view more data
100 Translational Medicine associated with AWT-020
Login to view more data
100 Patents (Medical) associated with AWT-020
Login to view more data
100 Deals associated with AWT-020
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MelanomaPhase 1
AU
Anwita Biosciences, Inc.Anwita Biosciences, Inc.
-
Non-Small Cell Lung CancerPhase 1
AU
Anwita Biosciences, Inc.Anwita Biosciences, Inc.
-
Renal Cell CarcinomaPhase 1
AU
Anwita Biosciences, Inc.Anwita Biosciences, Inc.
-
Transitional Cell CarcinomaPhase 1
AU
Anwita Biosciences, Inc.Anwita Biosciences, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
SITC2022
Not Applicable
-
-
jfieisfdrs(ldixfbwtaj) = AWT020 was well tolerated, with good exposure and long half-life fogapgyvpv (pgvsdxdgng )
-
07 Nov 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free